Prosecution Insights
Prosecution Insights
7 pending office actions • 5 art units • 5 examiners • 0 of 7 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (71%) |
| No statute on record | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BONAPARTE, AMY C | 2 | 79.8% | +23.1% |
| ROBINSON, MIKHAIL O'DONNEL | 2 | 56.8% | +41.6% |
| KASSA, TIGABU | 1 | 36.5% | +28.6% |
| CHONG, YONG SOO | 1 | 43.7% | +41.6% |
| KWON, JOHN SEUNGJAI | 1 | 45.7% | +23.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17156560 | PRODRUG FOR THE TREATMENT OF DISEASE AND INJURY OF OXIDATIVE STRESS | KWON, JOHN SEUNGJAI | 29d overdue |
| 18347896 | Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress | ROBINSON, MIKHAIL O'DONNEL | 1d overdue |
| 18770850 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | BONAPARTE, AMY C | 14d |
| 18678550 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | BONAPARTE, AMY C | 14d |
| 19173475 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE, DERIVATIVES AND TABLETS THEREOF | KASSA, TIGABU | 40d |
| 17701051 | TREATMENT OF FERROPTOSIS | CHONG, YONG SOO | 60d |
| 18597021 | Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress | ROBINSON, MIKHAIL O'DONNEL | — |
| Art Unit | Apps |
|---|---|
| 1692 | 2 |
| 1627 | 2 |
| 1619 | 1 |
| 1623 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19173475 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE, DERIVATIVES AND TABLETS THEREOF | KASSA, TIGABU | 1619 | §103 | Final Rejection | 40d | Pending | Apr 08, 2025 |
| 18770850 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | BONAPARTE, AMY C | 1692 | Other | Final Rejection | 14d | Pending | Jul 12, 2024 |
| 18678550 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | BONAPARTE, AMY C | 1692 | Other | Final Rejection | 14d | Pending | May 30, 2024 |
| 18597021 | Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress | ROBINSON, MIKHAIL O'DONNEL | 1627 | §103 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18347896 | Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress | ROBINSON, MIKHAIL O'DONNEL | 1627 | §103 | Non-Final OA | 1d overdue | Pending | Jul 06, 2023 |
| 17701051 | TREATMENT OF FERROPTOSIS | CHONG, YONG SOO | 1623 | §103 | Non-Final OA | 60d | Pending | Mar 22, 2022 |
| 17156560 | PRODRUG FOR THE TREATMENT OF DISEASE AND INJURY OF OXIDATIVE STRESS | KWON, JOHN SEUNGJAI | 1615 | §103 | Non-Final OA | 29d overdue | Pending | Jan 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial